<DOC>
	<DOCNO>NCT00571155</DOCNO>
	<brief_summary>The purpose study determine feasibility , efficacy safety intravenous oral antiepileptic treatment levetiracetam patient primary brain tumor symptomatic epilepsy period neurosurgical intervention .</brief_summary>
	<brief_title>Trial Levetiracetam Patients With Primary Brain Tumors Symptomatic Seizures Who Undergo Surgery</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>age ≥ 18 year suspect primary brain tumor image plan bioptical cytoreductive surgery tumor symptomatic epilepsy Karnofsky performance score ≥ 70 % woman child bear potential must perform sufficient contraception sufficient haematologic , hepatic renal function laboratory test treatment antiepileptic drug levetiracetam last seven day surgery know allergic reaction levetiracetam serious side effect know , tumorinduced , epilepsy previous brain surgery dementia participation another clinical trial addiction drug alcohol pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>